These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1898515)

  • 41. Melatonin, bone regulation and the ubiquitin-proteasome connection: A review.
    Vriend J; Reiter RJ
    Life Sci; 2016 Jan; 145():152-60. PubMed ID: 26706287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of glucocorticoids on bone cell metabolism and function.
    Peck WA
    Adv Exp Med Biol; 1984; 171():111-9. PubMed ID: 6372390
    [No Abstract]   [Full Text] [Related]  

  • 43. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
    Bar-Shavit Z
    Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cellular basis of metabolic bone disease.
    Rasmussen H; Bordier P
    N Engl J Med; 1973 Jul; 289(1):25-32. PubMed ID: 4575395
    [No Abstract]   [Full Text] [Related]  

  • 45. Aging of the Bone.
    Wei Y; Sun Y
    Adv Exp Med Biol; 2018; 1086():189-197. PubMed ID: 30232760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current developments in the study of bone and mineral metabolism].
    Herrmann-Erlee MP
    Ned Tijdschr Geneeskd; 1976 Apr; 120(14):614-20. PubMed ID: 176604
    [No Abstract]   [Full Text] [Related]  

  • 47. Bone physiology and the osteoporotic process.
    Smith R
    Respir Med; 1993 Feb; 87 Suppl A():3-7. PubMed ID: 8497713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of complement factor H alters bone architecture and dynamics.
    Alexander JJ; Sankaran JS; Seldeen KL; Thiyagarajan R; Jacob A; Quigg RJ; Troen BR; Judex S
    Immunobiology; 2018 Dec; 223(12):761-771. PubMed ID: 30107932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption.
    Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E
    J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiology: Foreman in the bone factory.
    Tromans A
    Nature; 2003 Oct; 425(6961):909. PubMed ID: 14586451
    [No Abstract]   [Full Text] [Related]  

  • 51. Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling.
    Edwards JR; Perrien DS; Fleming N; Nyman JS; Ono K; Connelly L; Moore MM; Lwin ST; Yull FE; Mundy GR; Elefteriou F
    J Bone Miner Res; 2013 Apr; 28(4):960-9. PubMed ID: 23172686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of Musculoskeletal Systems and Their Diseases. Bone metabolism and intercellular network].
    Terashima A; Takayanagi H
    Clin Calcium; 2015 Aug; 25(8):1133-40. PubMed ID: 26224669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
    Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
    Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prostaglandins].
    Shiraki M; Kaneki M
    Nihon Rinsho; 1990 Dec; 48(12):2811-7. PubMed ID: 2086838
    [No Abstract]   [Full Text] [Related]  

  • 55. [Melatonin and bone status].
    Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
    Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Notch signaling in bone formation and related skeletal diseases].
    Ma H; Wu Y; Zhang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Apr; 32(2):274-9. PubMed ID: 25863103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption.
    Chiao JW; Moonga BS; Yang YM; Kancherla R; Mittelman A; Wu-Wong JR; Ahmed T
    Br J Cancer; 2000 Aug; 83(3):360-5. PubMed ID: 10917552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of altered bone remodeling and retention of cement lines on bone quality in osteopetrotic aged c-Src-deficient mice.
    Nakayama H; Takakuda K; Matsumoto HN; Miyata A; Baba O; Tabata MJ; Ushiki T; Oda T; McKee MD; Takano Y
    Calcif Tissue Int; 2010 Feb; 86(2):172-83. PubMed ID: 20063091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Markers of bone turnover: biochemical and clinical perspectives.
    Pagani F; Francucci CM; Moro L
    J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of bone cell function by acid-base balance.
    Arnett T
    Proc Nutr Soc; 2003 May; 62(2):511-20. PubMed ID: 14506899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.